LRNDvsLGDSETF Comparison
JPMorgan Fundamental Data Science Large Growth ETF
NYLI U.S. Large Cap R&D Leaders ETF (LRND) belongs to the US Large Cap segment. JPMorgan Fundamental Data Science Large Growth ETF (LGDS) is part of the US Large Cap Growth segment. LRND's top 3 sector exposures are Technology, Healthcare and Consumer Non-Cyclicals. In contrast, LGDS's top sector exposures are Technology, Industrials and Healthcare. LRND is less expensive with a Total Expense Ratio (TER) of 0.15%, versus 0.4% for LGDS. Run a side-by-side ETF comparison of LRND and LGDS below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
LRND vs LGDS performance and flow charts
Performance
Cumulative Flows
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | LRND LGDS | -1.68%-2.83% | +7.18%+3.54% | +15.28%n/a | +14.00%n/a | +99.79%n/a | n/an/a |
| Flows | LRND LGDS | -$6M+$38M | +$25M-$55M | +$319M- | +$377M- | +$378M- | -- |
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | LRND LGDS | +17.30%+17.94% | +17.27%n/a | +17.80%n/a | n/an/a |
| Max drawdown | LRND LGDS | -6.46%-7.73% | -13.88%n/a | -20.97%n/a | n/an/a |
| Max drawdown duration | LRND LGDS | 21d21d | 169dn/a | 126dn/a | n/an/a |
LRND | LGDS | |
Last sale 10/28/2026 at 1:30 PM | $46.92 | $49.29 |
| Previous close 10/27/2026 | $46.84 | $49.00 |
| Consolidated volume 10/27/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Create an account to view replication metrics
LRND | LGDS | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
LRND | LGDS | |
|---|---|---|
| Last price | $46.92 | $49.29 |
| 1D performance | +0.16% | +0.59% |
| AuM | $441.40 M | $1.13 B |
| E/R | 0.15% | 0.4% |
LRND | LGDS | |
|---|---|---|
| Management strategy | Passive | Active |
| Provider | New York Life Investments | J.P. Morgan Asset Management |
| Benchmark | NYLI U.S. Large Cap R&D Leaders Index | - |
| N° of holdings | 100 | 100 |
| Asset class | Equities | - |
| Trailing 12m distribution yield | Join | Join |
| Inception date | February 8, 2022 | July 10, 2026 |
| ESG | No | No |
Countries
Sectors
Diversification
Total weight of top 15 holdings out of 15
Total weight of top 15 holdings out of 15
